Bone Marrow Transplantation News

SALT LAKE CITY — Patients with central nervous system lymphoma who underwent conditioning with thiotepa, busulfan and cyclophosphamide prior to autologous hematopoietic stem cell transplantation showed increased risk for DNA virus infections compared with patients with non-Hodgkin lymphoma who received traditional conditioning, according to retrospective study results presented at the BMT Tandem Meetings.

SALT LAKE CITY — The addition of elotuzumab and autologous peripheral blood mononuclear cell reconstitution to autologous hematopoietic stem cell transplantation plus lenalidomide maintenance appeared effective with a manageable safety profile, according to results of a phase 1b open-label trial presented at BMT Tandem Meetings.

SALT LAKE CITY — Endurance limitations appeared significantly associated with greater length of inpatient admission and death during admission for hematopoietic stem cell transplantation, according to study results presented at the BMT Tandem Meetings.

SALT LAKE CITY — Long-term survivors of childhood allogeneic hematopoietic stem cell transplantation have higher unemployment rates than the general U.S. population, according to study results presented at the BMT Tandem Meetings.

SALT LAKE CITY — Upfront high-dose chemotherapy with early autologous hematopoietic stem cell transplantation prolonged PFS compared with standard-dose chemotherapy or delayed transplantation among patients with newly diagnosed multiple myeloma, according to results of a meta-analysis presented at the BMT Tandem Meetings.

SALT LAKE CITY — Long-term follow-up clinics with telemedicine access can ensure hematopoietic stem cell transplant survivors receive appropriate care for symptoms and recommended screenings, according to a presenter at the BMT Tandem Meetings.

SALT LAKE CITY — Collecting patient-reported outcomes prior to hematopoietic stem cell transplantation may help predict clinical outcomes for patients after transplant, according to a presentation at the BMT Tandem Meetings.

HemOnc Today and Healio.com will provide live coverage from BMT Tandem Meetings, scheduled for Feb. 21-25 in Salt Lake City.

An analysis of hematopoietic stem cell transplant recipients in the United States over a 14-year period showed that patients with HIV do not have an increased risk for serious in-hospital complications despite having a potentially higher risk for certain opportunistic infections.

Professor Geoffrey Hill has been appointed director of hematopoietic stem cell transplantation at Fred Hutchinson Cancer Research Center.